Massivemarkets

Nasdaq: SCTX · Listed Jul 24, 2026

Scribe Therapeutics IPO

IPO price

$15.00

Scribe Therapeutics (SCTX) priced its IPO at $15.00 a share and has traded on Nasdaq since Jul 24, 2026.

SCTX today$14.25-5.00%since IPO15-min delayed · as of 4:24:20 AM EST on Nov 19, 2026

See the SCTX quote

First trading day · Jul 24, 2026

IPO price 15.00VWAP 23.30first trade 25.00+66.67% from the IPO price$22.00volume · rising bars above the line, falling bars below79.56K11:454:00
IPO price
$15.00
the top of the range of $13 to $15
First trade
$25.00
+66.67% from the IPO price
First-day last trade
$22.00
+46.67% from the IPO price, regular session
Raise
$128.7M
before the underwriters' option

These numbers are from the first trading day, Jul 24, 2026.

How SCTX did against the market

SCTX against the market, from its first trade at 11:45 ET to the last trade of the session.

SCTX from its first trade
-12.00%
Against the market (QQQ)
-11.2 pts

SCTX fell 12.0% from its first trade to the last trade of the session. That is 11.2 points worse than the market.

Same-day moves do not show that SCTX caused them. The market is QQQ, the Nasdaq-100 ETF.

The debut race

SCTX against other big listings, as the percent change from each stock's own IPO price.

The first 30 trading days. Each point is the last regular-session trade of a day.

+50%+100%+150%+200%+250%IPOday 1day 5day 10day 15day 20day 25day 30Figma '25 +69.64%Reddit '24 +40.32%CoreWeave '25 +28.42%Arm '23 -3.06%Klarna '25 -7.33%SCTX +104.80%

The IPO scoreboard

SCTX against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.

SCTX against other big IPOs: the money raised, and the return from each IPO price at the first trade, at the last trade of day 1, and on day 5 and day 30.
IPORaisedFirst tradeDay 1 closeDay 1 close, as a barDay 5Day 30
Scribe Therapeutics '26$128.7M+66.67%+46.67%+36.00%+104.80%
Figma '25$1.22B+157.58%+252.42%+173.64%+69.64%
Circle '25$1.05B+122.58%+168.45%+278.18%+622.98%
Reddit '24$748M+38.24%+47.97%+69.90%+40.32%
Arm '23$5.23B+10.00%+23.76%+3.63%-3.06%
Klarna '25$1.37B+30.00%+16.14%+13.73%-7.33%
CoreWeave '25$1.5B-2.50%+0.02%+34.32%+28.42%

Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.

The offering

The Scribe Therapeutics IPO offers 8.58M shares to raise $128.7M, before any underwriters' option.

$11$13$14$15$17
Expected price range
$13 to $15
IPO price
$15.00
Shares offered
8.58M
Money raised
$128.7M
Listing date
Jul 24, 2026
Exchange
Nasdaq
Security
Ordinary Shares

Money raised, against the largest IPOs

  • Alibaba '14$21.77B
  • Facebook '12$18.41B
  • Rivian '21$11.93B
  • Uber '19$8.1B
  • Arm '23$5.23B
  • Scribe Therapeutics$128.7M

Where SCTX ranks

Scribe Therapeutics's market cap against the largest US-listed companies.

Market cap, against the largest US-listed companies

  • AAPL$5.12T
  • MSFT$3.77T
  • NVDA$3.65T
  • GOOGL$3.47T
  • AMZN$2.9T
  • TSM$1.88T
  • AVGO$1.69T
  • META$1.58T
  • TSLA$1.52T
  • BRK.B$1.22T
  • SCTX$266.07M

SCTX news

The latest news and headlines about Scribe Therapeutics (SCTX).

Filings and the company

What Scribe Therapeutics has disclosed to the SEC, and the basic facts about the listing.

8-K filings

Material events that Scribe Therapeutics discloses to the SEC on Form 8-K.

  • Quarterly earningsNov 12, 2026

    On November 12, 2026, Scribe Therapeutics Inc. (the "Company") announced its financial results for the quarter ended September 30, 2026 and provided a business update.

  • On September 2, 2026, Scribe Therapeutics Inc. (the "Company") announced its financial results for the quarter ended June 30, 2026 and provided a business update.

  • Charter amendmentJul 27, 2026

    On July 27, 2026, Scribe Therapeutics Inc. (the "Company") filed its Amended and Restated Certificate of Incorporation (the "Charter") with the Secretary of State of the State of Delaware... in connection with the closing of the initial public offering (the "Offering") of shares of the Company's common stock.

About Scribe Therapeutics

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.

Ticker
SCTX
Exchange
Nasdaq
Market
stocks
Type
CS
Currency
USD
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
Jul 24, 2026
Security
Ordinary Shares
Company website

Frequently asked questions

What was the Scribe Therapeutics IPO price?

$15.00 a share.

When did Scribe Therapeutics go public?

Scribe Therapeutics listed on Nasdaq on Jul 24, 2026 under the ticker SCTX.

How much did the Scribe Therapeutics IPO raise?

$128.7M, before any underwriters' option.

How did Scribe Therapeutics open on its first day?

SCTX first traded at $25.00, +66.67% from the IPO price of $15.00.

How did SCTX close on its first day?

Its last regular-session trade was $22.00, +46.67% from the IPO price of $15.00.

What was the SCTX first-day trading range?

$21.00 to $25.49 in the regular session.

How many SCTX shares traded on the first day?

924.76K shares in the regular session.

How many shares did Scribe Therapeutics sell in its IPO?

8.58M shares.

How did SCTX do against the market on its first day?

SCTX fell 12.0% from its first trade to the last trade of the session. That is 11.2 points worse than the market (QQQ, the Nasdaq-100 ETF).

What exchange is SCTX listed on?

Scribe Therapeutics lists on Nasdaq under the ticker SCTX.

Build with Massive

Get the SCTX data behind this page

The Massive endpoint behind each section of this page
What the page showsEndpoint
Offering terms and dates/vX/reference/ipos
Price/v3/snapshot
Chart, VWAP, and the market comparison/v2/aggs/ticker/SCTX/range/5/minute
Market cap/v3/reference/tickers/SCTX
News/v2/reference/news
Filings/vX/disclosures

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.